Sarasota Memorial Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT00087126
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

gm602 (1 trial)

topotecan (hycamtin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2